| 000 | 01357 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512212801.0 | ||
| 264 | 0 | _c19830610 | |
| 008 | 198306s 0 0 eng d | ||
| 022 | _a0360-2532 | ||
| 024 | 7 |
_a10.3109/03602538308991391 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGreenblatt, D J | |
| 245 | 0 | 0 |
_aBenzodiazepine kinetics: implications for therapeutics and pharmacogeriatrics. _h[electronic resource] |
| 260 |
_bDrug metabolism reviews _c1983 |
||
| 300 |
_a251-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBenzodiazepines _xclassification |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aDiazepam _xmetabolism |
| 650 | 0 | 4 |
_aFlurazepam _xmetabolism |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNordazepam _xmetabolism |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 700 | 1 | _aDivoll, M | |
| 700 | 1 | _aAbernethy, D R | |
| 700 | 1 | _aOchs, H R | |
| 700 | 1 | _aShader, R I | |
| 773 | 0 |
_tDrug metabolism reviews _gvol. 14 _gno. 2 _gp. 251-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/03602538308991391 _zAvailable from publisher's website |
| 999 |
_c6404510 _d6404510 |
||